Kristin David
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, Diabetes Management and Research, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Quality of life in adults with nonalcoholic fatty liver disease(2009)159 cited
- → Daclizumab is Associated With Decreased Rejection and No Increased Mortality in Cardiac Transplant Patients Receiving MMF, Cyclosporine, and Corticosteroids(2005)39 cited
- → Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC®: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry(2008)20 cited
- → The association between MMF and risk of progressive renal dysfunction and death in adult liver transplant recipients with HCV(2009)11 cited
- Lowering A1c Through Integrated Behavioral Health Group Visits.(2021)
- [Incidence of spontaneous bacterial peritonitis in cirrhotic patients with ascites. A two-year prospective study].(1996)
- → Real-World Doxercalciferol Treatment in SHPT CKD Stage 3 and 4: An Analysis of Change in iPTH and Accordance to KDOQI Recommendations(2008)2 cited
- → Women’s Nontraditional Sexuality Questionnaire(2015)
- → Clinical Response in ABLC-Treated Mould Infections, the CLEAR II™ Registry.(2005)
- → Premedication Practices and Incidence of Infusion-related Reactions in Patients Receiving AMPHOTEC: Data from the PRoACT-Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability(2008)